DATASHEET
Host:
Rabbit
Target Protein:
Thrombin Activation peptide fragment 1
Immunogen Range:
51-150/622
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
2147
Source:
KLH conjugated synthetic peptide derived from human Thrombin Activation peptide fragment 1
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Thrombin is the final protease in the blood coagulation cascade and serves both pro- and anticoagulant functions through the cleavage of several targets. The ability of thrombin to specifically recognize a wide range of substrates derives from interactions which occur outside of the active site of thrombin. Thrombin possesses two anion binding exosites which mediate many of its interactions with cofactors and substrates, and although many structures of thrombin have been solved, few such interactions have been described in molecular detail. Glycosaminoglycan binding to exosite II of thrombin plays a major role in switching off the procoagulant functions of thrombin by mediating its irreversible inhibition by circulating serpins and by its binding to the endothelial cell surface receptor thrombomodulin.
VALIDATION IMAGES
Lane 1: Mouse placenta lysates;Lane 2: Mouse embryo lysates; Lane 3:Mouse Liver lysates probed with Thrombin Activation peptide fragment 1Polyclonal Antibody, Unconjugated (bs-10387R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Mouse Uterus lysates; Lane 2: Rat Kidney lysates probed with Thrombin Activation peptide fragment 1 Polyclonal Antibody, Unconjugated (bs-10387R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C